Document is current
Any future updates will be listed below
-
Authors
Chiappa, Michela https://orcid.org/0000-0001-6177-4796
Decio, Alessandra
Guarrera, Luca https://orcid.org/0000-0001-7475-3345
Mengoli, Ilaria
Karki, Anju
Yemane, Divora
Ghilardi, Carmen
Scanziani, Eugenio
Canesi, Simone https://orcid.org/0000-0002-9561-5248
Barbera, Maria C. https://orcid.org/0000-0003-1627-0032
Craparotta, Ilaria
Bolis, Marco
Fruscio, Robert
Grasselli, Chiara
Ceruti, Tommaso
Zucchetti, Massimo
Patterson, Jesse C.
Lu, Robin A.
Yaffe, Micheal B. https://orcid.org/0000-0002-9547-3251
Ridinger, Maya https://orcid.org/0000-0001-5833-5573
Damia, Giovanna https://orcid.org/0000-0001-9749-434X
Guffanti, Federica https://orcid.org/0000-0001-7723-9974
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG19797)
- License Information
-
More Information
Article History
Received: 9 November 2023
Revised: 3 July 2024
Accepted: 5 July 2024
First Online: 22 July 2024
Competing interests
: Divora Yemane, Anju Karki, and Maya Ridinger are employees and shareholders of Cardiff Oncology Inc. All other authors declare no potential conflicts of interest.
: This study was conducted in compliance with the principles of the Declaration of Helsinki. Informed consent was obtained from all the subjects. All the experiments involving animals were conducted upon approval by the institutional review board and the Italian Ministry of Health (approval number: 475/2017-PR).
